cornerstone therapeutics (CRTX)

- nasdaq
$8.54 May 21, 2013-04:00 PM ET
Chart_CRTX_365_13.jpg
Chart Type 1D 5D 1M 3M 6M 1Y 2Y 5Y

 

Prev Close: $8.94 Day's Range: $8.481 - $8.93
Open: $8.92 52wk Range: $3.1 - $9.13
P/E Ratio: 0 Volume: 73,427
Beta: 0.44 Avg Vol (3m): 86,047
Div & Yield: Market Cap(Mil.): 240
EPS (ttm): -0.29 P/E (ttm): -23.79

cornerstone therapeutics News
  • Cornerstone Therapeutics Q1 Non-GAAP EPS More Than Quadruples To $0.24 From $0.05 Last Year
    5/9/2013
  • Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights To PERTZYE
    5/9/2013
  • Cornerstone Therapeutics Q4 Loss/Shr $0.26 Vs. Loss $0.11 Last Year
    3/14/2013
  • Cornerstone Therapeutics Announces Receipt Of Take-Private Proposal From Its Majority Stockholder Chiesi Farmaceutici
    2/20/2013
  • Cornerstone Therapeutics Buys Exclusive U.S. Rights To Chiesi Farmaceutici S.p.A.'s BETHKIS
    11/8/2012
  • Cornerstone Therapeutics Q3 EPS $0.05
    11/8/2012
  • Cornerstone Therapeutics Names Alastair McEwan CFO
    11/7/2012

Next 10 Headlines
Copyright © 2013 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.
Privacy   |   Feedback   |   Sitemap